Latest News- Pharmaceutical Contract Manufacturing Market: Big pharmaceutical companies is expected to lead the End-user segment during 2024-2028

The Pharmaceutical Contract Manufacturing Market is being driven by Patent expiry and increasing demand for generic drugs

The Pharmaceutical Contract Manufacturing Market is expected to grow at a CAGR of 8.1% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 64.8 billion. The pharmaceutical contract manufacturing market is experiencing a significant trend with the rising approval of US FDA-certified facilities in emerging economies, particularly China and India. India, home to approximately 400 US FDA-approved manufacturing facilities, is a favored destination for pharmaceutical manufacturing outsourcing. With around 230 approved Active Pharmaceutical Ingredient (API) facilities and 150 FDA-approved facilities, India leads the world in this category. Additionally, India houses approximately 147 formulation facilities, the second-highest number globally. The market is also witnessing an upsurge in FDA approvals for manufacturing facilities in emerging economies such as China, India, Mexico, and Brazil. 

Get more information on Pharmaceutical Contract Manufacturing Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• End-user
  • Big pharmaceutical companies
  • Small and medium-sized pharmaceutical companies
  • Generic pharmaceutical companies
• Service
  • API/bulk drug manufacturing
  • Final dosage form
  • Secondary packaging
• Geography
  • North America
    • US
  • Asia
    • China
    • India
  • Europe
    • Germany
    • UK
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Patent expiry and increasing demand for generic drugs
• Growing need to focus on core competencies
• Strong research funding

However, the market also witnesses some limitations, which are as follows:

• Capacity utilization and constraints
• Stereotypical nature of CMOs
• Stringent regulations on CMOs

Benefits of Buying Global Pharmaceutical Contract Manufacturing Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Pharmaceutical Contract Manufacturing Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Pharmaceutical Contract Manufacturing Market involves outsourcing various aspects of drug production to contract manufacturers, including drug formulation, biologic manufacturing, and personnel training. This market caters to small, mid-sized, and large pharmaceutical companies, specializing in generic drugs and drug development. Bioprocess outsourcing hubs focus on antibiotics pipelines and Pharma serialization solutions. CMOs offer services for personalized medicines, such as antibody-drug conjugates and anti-cancer therapies, particularly in the oncology drugs market. Contract manufacturing organizations play a crucial role in the pharmaceutical supply chains, supporting the production of a wide range of pharmaceutical products.

Market Research Overview

The Pharmaceutical Contract Manufacturing Market is a significant segment of the global healthcare equipment market, focusing on outsourced manufacturing services for drug formulation, development, and production. Contract manufacturers specialize in producing generic drugs, high-potency drugs, and specialized delivery systems for pharmaceutical companies. Quality control and assurance are paramount, ensuring compliance with regulatory standards. Technavio, a leading market research firm, categorizes this market as part of the global healthcare equipment industry, which encompasses R&D of capital equipment, instruments, implants, accessories, and consumables for disease diagnosis, monitoring, and treatment. The global healthcare equipment market size is determined by the combined revenue generated by manufacturers of diagnostic equipment and devices. The healthcare equipment sector consists of the Devices segment, which includes advanced, differentiated, and clinically tested devices.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/